These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 34113015)

  • 41. Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.
    Wang Y; Yang C; Song Y; Coleman JR; Stawowczyk M; Tafrova J; Tasker S; Boltz D; Baker R; Garcia L; Seale O; Kushnir A; Wimmer E; Mueller S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34193524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of COVID-19 vaccination strategies with a delayed second dose.
    Moghadas SM; Vilches TN; Zhang K; Nourbakhsh S; Sah P; Fitzpatrick MC; Galvani AP
    PLoS Biol; 2021 Apr; 19(4):e3001211. PubMed ID: 33882066
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vaccine hesitancy in the COVID-19 era.
    Adhikari B; Cheah PY
    Lancet Infect Dis; 2021 Aug; 21(8):1086. PubMed ID: 34217431
    [No Abstract]   [Full Text] [Related]  

  • 44. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
    Behr MA; Divangahi M; Schurr E
    J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COVID-19 vaccine effectiveness among the staff of the Bologna Health Trust, Italy, December 2020-April 2021.
    Giansante C; Stivanello E; Perlangeli V; Ferretti F; Marzaroli P; Musti MA; Pizzi L; Resi D; Saraceni S; Pandolfi P
    Acta Biomed; 2021 Sep; 92(4):e2021270. PubMed ID: 34487060
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of population mixing between vaccinated and unvaccinated subpopulations on infectious disease dynamics: implications for SARS-CoV-2 transmission.
    Fisman DN; Amoako A; Tuite AR
    CMAJ; 2022 Apr; 194(16):E573-E580. PubMed ID: 35470204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination.
    Butt AA; Nafady-Hego H; Chemaitelly H; Abou-Samra AB; Khal AA; Coyle PV; Kanaani ZA; Kaleeckal AH; Latif AN; Masalmani YA; Bertollini R; Raddad LJA
    Int J Infect Dis; 2021 Sep; 110():353-358. PubMed ID: 34375762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong.
    Lai FTT; Huang L; Chui CSL; Wan EYF; Li X; Wong CKH; Chan EWW; Ma T; Lum DH; Leung JCN; Luo H; Chan EWY; Wong ICK
    Nat Commun; 2022 Jan; 13(1):411. PubMed ID: 35058463
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness of COVID-19 vaccine in preventing infection and disease severity: a case-control study from an Eastern State of India.
    Singh C; Naik BN; Pandey S; Biswas B; Pati BK; Verma M; Singh PK
    Epidemiol Infect; 2021 Oct; 149():e224. PubMed ID: 34632972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of COVID-19 vaccines on the Case Fatality Rate: The importance of monitoring breakthrough infections.
    di Lego V; Sánchez-Romero M; Prskawetz A
    Int J Infect Dis; 2022 Jun; 119():178-183. PubMed ID: 35398301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Persuading US White evangelicals to vaccinate for COVID-19: Testing message effectiveness in fall 2020 and spring 2021.
    Bokemper SE; Gerber AS; Omer SB; Huber GA
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845032
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statistical mechanics study of the introduction of a vaccine against COVID-19 disease.
    De-Leon H; Pederiva F
    Phys Rev E; 2021 Jul; 104(1-1):014132. PubMed ID: 34412259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France.
    Bosetti P; Tran Kiem C; Andronico A; Colizza V; Yazdanpanah Y; Fontanet A; Benamouzig D; Cauchemez S
    BMC Med; 2022 Jan; 20(1):33. PubMed ID: 35078469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021.
    de Gier B; Andeweg S; Joosten R; Ter Schegget R; Smorenburg N; van de Kassteele J; ; Hahné SJ; van den Hof S; de Melker HE; Knol MJ;
    Euro Surveill; 2021 Aug; 26(31):. PubMed ID: 34355689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. COVID-19 vaccination status and testing rates in Finland-A potential cause for bias in observational vaccine effectiveness analysis.
    Kuitunen I; Uimonen M; Seppälä SJ; Ponkilainen VT
    Influenza Other Respir Viruses; 2022 Sep; 16(5):842-845. PubMed ID: 35475567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. COVID-19 vaccinations for patients with cancer: many remain unvaccinated despite having priority in the vaccine rollout.
    Body A; Ahern E; Segelov E
    Intern Med J; 2021 Oct; 51(10):1760. PubMed ID: 34664360
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of hospitalizations and deaths from COVID-19 2021
    Donzelli A; Alessandria M; Orlando L
    F1000Res; 2021; 10():964. PubMed ID: 34909193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SARS-CoV-2 Transmission and Impacts of Unvaccinated-Only Screening in Populations of Mixed Vaccination Status.
    Bubar KM; Middleton CE; Bjorkman KK; Parker R; Larremore DB
    medRxiv; 2022 Mar; ():. PubMed ID: 34909778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccination strategies against COVID-19 and the diffusion of anti-vaccination views.
    Prieto Curiel R; González Ramírez H
    Sci Rep; 2021 Mar; 11(1):6626. PubMed ID: 33758218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons.
    Kissler SM; Fauver JR; Mack C; Tai CG; Breban MI; Watkins AE; Samant RM; Anderson DJ; Metti J; Khullar G; Baits R; MacKay M; Salgado D; Baker T; Dudley JT; Mason CE; Ho DD; Grubaugh ND; Grad YH
    N Engl J Med; 2021 Dec; 385(26):2489-2491. PubMed ID: 34941024
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.